Bull case
The bull case prices MMM at 15x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where MMM stock could go
The bull case prices MMM at 15x on FY1 earnings, assuming continued execution and no meaningful deceleration in the core business.
This is close to how the market is already pricing MMM — at roughly 17x forward earnings. No dramatic re-rating needed, just steady execution on the core business.
If investor confidence fades or macro conditions deteriorate, a 11x multiple contraction could push MMM down roughly 65% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

3M is a diversified industrial conglomerate that manufactures thousands of industrial, consumer, and healthcare products — from Post-it Notes and Scotch tape to medical supplies and industrial adhesives. It generates revenue through four main segments: Safety & Industrial (~35%), Transportation & Electronics (~25%), Health Care (~25%), and Consumer (~15%). The company's competitive moat lies in its massive patent portfolio — over 60,000 patents — and its deep expertise in materials science that enables it to create innovative products across diverse markets.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $2.16/$2.01 | +7.5% | $6.3B/$6.1B | +3.7% |
| Q4 2025 | $2.19/$2.07 | +5.8% | $6.5B/$6.2B | +4.3% |
| Q1 2026 | $1.83/$1.80 | +1.7% | $6.0B/$6.0B | -0.1% |
| Q2 2026 | $2.14/$1.98 | +8.1% | $6.0B/$6.0B | -0.1% |
MMM beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $138 — implies -3.4% from today's price.
| Metric | MMM | S&P 500 | Industrials | 5Y Avg MMM |
|---|---|---|---|---|
| Forward PE | 16.4x | 19.1x-14% | 20.7x-21% | — |
| Trailing PE | 23.8x | 25.1x | 25.7x | 17.1x+39% |
| PEG Ratio | — | 1.72x | 1.64x | — |
| EV/EBITDA | 15.1x | 15.2x | 13.7x+11% | 12.8x+18% |
| Price/FCF | 53.4x | 21.1x+153% | 21.2x+152% | 42.6x+25% |
| Price/Sales | 3.0x | 3.1x | 1.6x+88% | 2.5x+19% |
| Dividend Yield | 1.53% | 1.87% | 1.27% | 4.11% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolMMM generates $2.1B in free cash flow at a 8.2% margin — 28.1% ROIC signals a durable competitive advantage · returns 8.0% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
~3.7 years to full repayment at current FCF run-rate
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
3M has faced multiple high‑value settlements, including a $6 billion earplug payout and a $10.3 billion PFAS water‑contamination settlement. Ongoing lawsuits over products such as the Bair Hugger warming blanket add further exposure that could erode recent gains.
The company’s debt‑to‑equity ratio stands at 3.39, and large settlements have strained cash flows. Rising interest rates or additional liabilities could limit future investment and growth initiatives.
Commodity price volatility, production cost increases, and potential recalls threaten manufacturing efficiency and product quality, potentially impacting margins.
The divestiture of the Health Care segment (Solventum) has reduced diversification, making 3M more sensitive to sector‑specific downturns and less able to buffer market swings.
3M is phasing out PFAS production by 2025 amid tightening regulations; non‑compliance could trigger penalties and reputational harm.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
3M operates across safety, industrial, transportation, electronics, and consumer markets, creating a broad revenue base that cushions against sector downturns. This multi‑segment footprint supports steady top‑line growth and cross‑sell opportunities.
Analysts project modest single‑digit EPS growth, with revenue expected to rise 4.60% and EPS 5.67%. Some forecasts see upside potential exceeding 50%, reflecting confidence in 3M’s earnings trajectory.
The company consistently beats earnings expectations, with improving ROA, ROE, and ROIC relative to its three‑year averages. Robust free‑cash‑flow conversion further underpins its financial resilience.
DCF models place 3M’s fair value at $177.32 per share, implying a 19% upside from the recent $144.47 price, while another model values it at $211.02, a 31.5% discount to current levels. These valuations suggest the stock is undervalued.
3M is expanding optical technology manufacturing to meet data‑center and AI demand, and restructuring efforts aim to boost efficiency and margins. These moves position the company for growth in high‑margin tech segments.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
MMM MMM 3M Company | $74.5B | 16.4x | -2.1% | 11.1% | Hold | +16.8% |
HON HON Honeywell International Inc. | $132.5B | 19.9x | +6.1% | 11.2% | Buy | +16.6% |
EMR EMR Emerson Electric Co. | $77.8B | 21.3x | +4.2% | 13.3% | Buy | +17.0% |
ITW ITW Illinois Tool Works Inc. | $73.4B | 22.6x | +1.8% | 19.3% | Hold | +7.5% |
ETN ETN Eaton Corporation plc | $159.4B | 30.9x | +10.3% | 14.0% | Buy | -7.6% |
PH PH Parker-Hannifin Corporation | $110.1B | 28.1x | +2.5% | 16.6% | Buy | +19.4% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
MMM returns capital mainly through $4.8B/year in buybacks (6.5% buyback yield), with a modest 1.53% dividend — combining for 8.0% total shareholder yield.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.78 | — | — | — |
| 2025 | $2.92 | -13.2% | 5.6% | 6.9% |
| 2024 | $3.36 | -33.0% | 2.5% | 5.3% |
| 2023 | $5.02 | +0.7% | 0.1% | 6.6% |
| 2022 | $4.98 | +0.7% | 2.6% | 8.5% |
Common questions answered from live analyst data and company financials.
3M Company (MMM) is rated Hold by Wall Street analysts as of 2026. Of 33 analysts covering the stock, 15 rate it Buy or Strong Buy, 17 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $167, implying +16.8% from the current price of $143. The bear case scenario is $51 and the bull case is $134.
The Wall Street consensus price target for MMM is $167 based on 33 analyst estimates. The high-end target is $190 (+33.0% from today), and the low-end target is $136 (-4.8%). The base case model target is $144.
MMM trades at 16.4x times forward earnings. The stock's valuation is broadly in line with the broader market. Based on current multiples versus the peer group, the relative model signals fairly valued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for MMM in 2026 are: (1) Litigation & Legal Liabilities — 3M has faced multiple high‑value settlements, including a $6 billion earplug payout and a $10. (2) Financial Strain from Settlements — The company’s debt‑to‑equity ratio stands at 3. (3) Operational & Supply Chain Risks — Commodity price volatility, production cost increases, and potential recalls threaten manufacturing efficiency and product quality, potentially impacting margins. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates MMM will report consensus revenue of $24.5B (-2.1% year-over-year) and EPS of $6.25 (+19.5% year-over-year) for the upcoming fiscal year. The following year, analysts project $24.1B in revenue.
A confirmed upcoming earnings date for MMM is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
3M Company (MMM) generated $2.1B in free cash flow over the trailing twelve months — a free cash flow margin of 8.2%. MMM returns capital to shareholders through dividends (1.5% yield) and share repurchases ($4.8B TTM).